Neurotrack
Neurotrack
Prevent cognitive decline
Human health & social work | United States of America | Disease Specific Prevention and Mitigation |
Overview
Neurotrack's technology can predict the onset of Alzheimer's disease three to six years before symptoms occur. Based on groundbreaking research Neurotrack's technology will give pharmaceutical companies and CROs the tools to recruit optimal candidates for clinical trials and more effectively measure drug efficacy speeding up drug development.rnrnNeurotrack is on course to provide the standard for early clinical screening of Alzheimer's disease and dementia related disorders.
Industry |
Legal Structure |
Operating Status |
Employees |
Human health & social work | Operating |
Funding and Financing Rounds
May, 2013 / $900K / Seed
Undisclosed
$50K / Seed
Team
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
Impact Reports & Metrics
Offices
Head Office
399 Bradford St
Redwood City, California 94063
United States of America